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A B S T R A C T
As critical regulators of brain homeostasis, microglia are influenced by numerous factors, including sex and
genetic mutations. To study the impact of these factors on microglia biology, we employed genetically en-
gineered mice that model Neurofibromatosis type 1 (NF1), a disorder characterized by clinically relevant
sexually dimorphic differences. While microglia phagocytic activity was reduced in both male and female het-
erozygous Nf1 mutant (Nf1+/−) mice, purinergic control of phagocytosis was only affected in male Nf1+/−
mice. ATP-induced P2Y-mediated membrane currents and P2RY12-dependent laser lesion-induced accumulation
of microglial processes were also only impaired in male, but not female Nf1+/−, microglia. These defects
resulted from Nf1+/− male-specific defects in cyclic AMP regulation, rather than from changes in purinergic
receptor expression. Cyclic AMP elevation by phosphodiesterase blockade restored the male Nf1+/− microglia
defects in P2Y-dependent membrane currents and process motility. Taken together, these data establish a sex-by-
genotype interaction important to microglia function in the adult mouse brain.
1. Introduction
The implementation of precision medicine requires the identifica-
tion of the risk factors that underlie disease pathogenesis and pro-
gression (Wegscheid et al., 2018; Bennett and Bennett, 2020; Yirmiya
et al., 2015; Wright-Jin and Gutmann, 2019). In the setting of central
nervous system (CNS) disease, microglia have emerged as one of the
key cell types important for modifying pathobiology and integrating
risk factors. As such, microglia serve important functions in the de-
velopment and evolution of numerous CNS disorders, ranging from
autism to Alzheimer's disease (Wolf et al., 2017; Whitelaw, 2018). In
addition to actively participating in disease pathogenesis, risk factors,
such as the germline mutation (e.g., ApoE status, Krasemann et al.,
2017) and sex (Hanamsagar et al., 2017; McCarthy and Wright, 2017;
Guneykaya et al., 2018), alter microglia function. In this regard, sexu-
ally dimorphic differences in microglia function can impact on CNS
disease development (Vegeto et al., 2020; Kerr et al., 2019; Fisher et al.,
2018; Nissen, 2017).
To explore the impact of germline genetics and sex in the setting of a
common neurodevelopmental disorder characterized by microglia
dysfunction, we focused on the monogenic syndrome,
Neurofibromatosis type 1 (NF1). Caused by germline mutations in the
NF1 gene, children with NF1 are prone to brain tumours, in particular,
optic pathway gliomas (OPGs), and autism, as well as learning dis-
abilities, attention deficits, and motor function delays (Gutmann et al.,
2017). Moreover, some of these CNS phenotypes are sexually di-
morphic: whereas autism is more common in male in the general po-
pulation, this male predominance is dramatically attenuated in children
with NF1 (Morris et al., 2016). Similarly, girls with NF1-OPGs are 3- to
5-times more likely than boys to lose vision from their tumours and
require treatment (Diggs-Andrews et al., 2014b; Diggs-Andrews et al.,
2014a). In Nf1 optic glioma mice, this sex-specific effect operates at the
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level of microglia, where estrogen binding to the estrogen receptor-beta
on microglia underlies the observed retinal ganglion cell loss, nerve
fibre layer thinning, and visual acuity reduction (Toonen et al., 2017).
To explore additional sex-specific differences uncovered by Nf1
mutation, we leveraged Nf1mutant mice, genetically similar to patients
with NF1 harboring one mutant germline Nf1 allele. We identified
male-specific defects in purinergic function, including phagocytosis,
process movement, and ATP induced membrane currents, which result
from impaired cyclic AMP signaling. Collectively, these findings es-
tablish sex-by-genotype microglial abnormalities in the setting of Nf1
mutation.
2. Materials and methods
2.1. Ethics statement
All procedures involving the handling of living mice were per-
formed in strict accordance with the German Animal Protection Law,
and were approved by the Regional Office for Health and Social
Services in Berlin (Landesamt für Gesundheit und Soziales, Berlin,
Germany, Permit Number T0014/08, X9023/12, X9005/18, A0376/17)
and the Washington University Animal Studies Committee. Adult mice
were euthanized by cervical dislocation or by transcardial perfusion of
PBS or PFA after intraperitoneal injection of pentobarbital (Narcoren,
Merial GmbH, Hallbergmoos, Germany). All efforts were made to
minimize suffering.
2.2. Mice
Wild type and Nf1+/− (Brannan et al., 1994) mice used in this
study, either bred onto a wild type or MacGreen (Csf1r-eGFP; Sasmono
et al., 2003) C57/BL6 background, were kept under a 12 h/12 h dark-
light cycle with food and water supply ad libitum, in accordance with
German laws for animal protection.
2.3. Acute brain slice preparation
Acute cortical brain slices were prepared as previously described
(Boucsein et al., 2003). In brief, mice were euthanized by cervical
dislocation, and their brains removed and cooled in ice-cold artificial
cerebrospinal fluid (aCSF) containing (in mM): 230 Sucrose, 2.5 KCl, 10
MgSO4, 0.5 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, and 10 D-glucose,
pH 7.4; gassed with 95% O2/ 5% CO2. Brains were then mounted on a
vibratome (HM650V, Thermo Scientific, Massachusetts, USA), and
250 μm thick coronal brain slices were generated and kept at room
temperature for experiments for up to 5 h in gassed ACSF containing (in
mM): 134 NaCl, 2.5 KCl, 1.3 MgCl2, 2 CaCl2, 1.26 K2HPO4, 26 NaHCO3,
and 10 D-glucose (pH 7.4). Acute brain slices were used for patch clamp
recordings and in situ 2-photon live-cell imaging.
2.4. Immunohistochemistry, confocal microscopy and microglial density
analysis
For the immunohistochemical analysis, animals were deeply an-
esthetized with ketamine, perfused with phosphate buffered saline
(PBS) solution, followed by 4% PFA in PBS. Afterwards, mice were
decapitated, and their brains removed and sectioned in the coronal
plane at 40 μm thickness using a sliding dry-iced-cooled microtome.
Free-floating sections were incubated for 1 h in 5% donkey serum and
0.1% Triton-X in Tris-buffered saline solution (TBSplus).
For microglial density analysis, goat anti-Iba1 (Abcam, ab5076)
primary antibody was diluted 1:250 in TBS plus and incubated over-
night at 4 °C. The secondary antibody, donkey anti-goat Alexa Fluor
488 (Dianova, 705–545-147), was also prepared in TBS plus at a dilu-
tion of 1:200, and cell nuclei were labeled using 4′,6-diamidino-2-
phenylindole (DAPI, Dianova) at a dilution of 1:200, for two hours at
room temperature. Sections were subsequently mounted in Aqua
Polymount on glass slides for analysis.
Images were acquired using a confocal microscope equipped with a
10× objective and LASAF software (Leica TCS SPE, Leica microsystem).
Pictures were taken throughout the entire thickness of the slice by z-
stacking (3 μm z-step size, 13 steps).
The number of microglia cells per mm2 was quantified using Fiji
ImageJ software followed by analysis with Cell Profiler® automated cell
counter software (https://cellprofiler.org/). A total of four slices per
brain region and animal were analyzed. Briefly, the desired areas of
interest (brain region) were selected in Image J on the the maximum
intensity z-projection of the confocal scans. Channels were split into
separate TIF images for analysis with a modified cell profiler protocol
(Bloomfield et al., 2018). Microglial cell number was quantified using
modified parameters, including typical diameter object sizes between
0.5 and 50, and a lower threshold value of 0.35. For the DAPI channel,
the diameter object size was set to 10–50 (arbitrary units). A further
filter step that incorporates microglial cell body size was set to 25. Once
extrapolated, the microglia counts in the different brain regions, the
average of four independent images, were normalized, based on the
quantified area in mm2. Data are presented as number of microglia
cells/mm2.
2.5. Adult microglia cultures
Microglia from (12–16 weeks old) adult mice were prepared as
described previously (Pannell et al., 2016). Briefly, brains obtained
from adult male and female WT and Nf1+/−mice (12–16 weeks) were
freed of blood vessels and meninges, mechanically dissociated, and
digested with trypsin and DNAse. Cells were then plated onto a con-
fluent monolayer of P0-P2 WT astrocytes in 75 cm2 flasks. The feeder
astrocyte layer was depleted of neonatal microglial cells using chlo-
dronate (200 μg/ml) before adding microglia. Mixed adult and neonatal
microglial cultures were maintained in fresh complete DMEM, and the
medium changed every third day, followed by addition of 33% L292-
conditioned medium at day 7. One week later, cells were shaken off,
and used for experiments within 24–48 h.
2.6. In situ phagocytosis assay
The phagocytosis assay was performed as previously described
(Wendt et al., 2017; Pan et al., 2018). Briefly, 130 μm acute coronal
brain slices from 14 to 16 week-old Nf1+/− mice and their WT lit-
termates (n = 5–6, for AR-C66096 condition n = 2–3) were used.
Brains were sliced in ice-cold ACSF buffer solution containing (in mM):
NaCl, 134; KCl, 2.5; MgCl2, 1.3; CaCl2, 2; K2HPO4, 1.25; NaHCO3, 26; D-
glucose, 10; pH 7.4; gassed with 95% O2 and 5% CO2 using a vibratome
(HM650V, Thermo Scientific, Massachusetts, USA). Slices rested for 2 h
at room temperature in ACSF, which was constantly gassed with car-
bogen (95% O2 and 5% CO2). The slices were subsequently incubated
for 1 h at 37 °C (95% O2 / 5% CO2) with Bright Blue fluorescent car-
boxylated microspheres (4.5 μm diameter, Polysciences, Hirschberg an
der Bergstraße, Germany) to allow for phagocytosis (with the corre-
sponding chemicals to the included conditions). Prior to incubation,
microspheres were opsonized by shaking in FCS at 1000 rpm for 30 min
at room temperature and centrifuged (2 min at 3000 rpm, Eppendorf
Centrifuge 5417R- Rotor FA45–30-11; rotor radius metric: 9.5 cm),
washed in PBS and resuspended in HBSS. Each brain slice was in-
cubated with 2.45 × 106 microspheres with a 4.5 μm diameter in a
volume of 500 μl HBSS. UDP (100 μM), MRS2578 (5 μM) or AR-C66096
(1 μM) were added to the HBSS-microsphere suspension during the 1 h
incubation period. Brain slices were washed after microsphere treat-
ment 3 × 20 min in 0.1 M PBS at pH 7.4, fixed with 4% PFA for 1 h at
room temperature, and then stored at 4 °C. For staining with Iba1, fixed
slices were incubated for 4 h at room temperature in blocking buffer
containing 2% Triton X-100, 2% bovine serum albumin and 10%
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donkey serum in 0.1 M PBS, pH 7.4. First, incubation with goat poly-
clonal anti-Iba1 antibody (1:600, Abcam, Berlin, Germany) was per-
formed overnight at 4 °C in staining buffer (1:10 dilution of blocking
buffer in 0.1 M PBS pH 7.4). Slices were incubated with secondary
antibody (1:250 in staining buffer; Alexa Fluor 647-labeled donkey
anti-goat antibody; Invitrogen, Karlsruhe, Germany) for 2 h at room
temperature following 3 × 20 min washes in 0.1 M PBS, pH 7.4. Slices
were mounted in Aqua-Poly/Mount (Polysciences). For confocal ima-
ging of microglia and microspheres, cortical view fields were randomly
chosen within the cortex, 21 μm thick z-stacks at 1.05 μm intervals
beginning from the surface of each slice were acquired. We used a
confocal laser-scanning microscope from Leica (TCS SPE) and a 20× oil
immersion objective. Data analysis to assess microglial phagocytic ac-
tivity was performed using Imaris 9.1 (Bitplane, Zürich, Switzerland).
The Iba1+ cell volumes of high-resolution SPE confocal microscopy
stacks were 3D surface-rendered after “background subtraction” (1–3
times; 90 μm each) and thresholding using values of 25–40. Detection
of microspheres within the rendered Iba1+ cell volume was performed
automatically by the “split into surface object” plug-in. The phagocytic
index (PI) was calculated by the following equation: nPM*104/VIba1
where nPM is the number of phagocytosed microspheres and VIba1 is the
volume of Iba1 fluorescence in μm3. The student's t-test was used to
compare each condition separately between Nf1+/− and WT groups.
2.7. Electrophysiological recordings
Conventional patch-clamp amplifiers were used (EPC9 and EPC10,
HEKA Elektronik, Lambrecht, Germany). Acute 250 μm coronal brain
slices were prepared from Nf1+/− and wild type mice generated on a
MacGreen background (Sasmono and Williams, 2012) for microglia
identification by fluorescence on an epifluorescent microscope. Patch
pipettes were pulled from borosilicate glasses and had resistances of
4–6 MΩ. The following intracellular solution was used (in mM): KCl,
130; MgCl2, 2; CaCl2, 0.5; Na-ATP, 2; EGTA, 5; HEPES, 10 and sulfor-
hodamine 101, 0.01 (Sigma Aldrich,) and had an osmolarity of
280–290 mOsm/L adjusted to a pH of 7.3 with KOH. The extracellular
solution contained (in mM): NaCl, 134; KCl, 2.5; MgCl2, 1.3; CaCl2, 2;
K2HPO4, 1.25; NaHCO3, 26; D-glucose, 10; pH 7.4; 310–320 mOsm/L
and was gassed with carbogen (95% O2/ 5% CO2). Experiments with
series resistances less than ~65 MΩ were used for data analysis. All
experiments were performed in the voltage-clamp configuration. To
obtain current-voltage curves during continuous recordings, the mem-
brane was clamped every 5 s from a holding potential of −70
or − 20 mV (basal current and ATP-induced current, respectively) to a
series of de- and hyperpolarizing voltages ranging from −140 mV to
60 mV with 20 mV increment, 100 ms in duration. Membrane currents
were averaged for quantification between 30 and 45 ms after clamping
the membrane to a given value from the resting potential. Membrane
capacitance was quantified based on an exponential fit of the current
decay in response to a − 10 mV test pulse. The same pulse was used to
quantify series resistance from the peak amplitude of the membrane
capacitance currents. Comparisons of membrane currents between
different groups were always normalized to the membrane capacitance.
2.8. Two-photon imaging and laser lesioning
Live imaging of microglial processes was performed on 250 μm
coronal brain slices from Nf1+/− mice and their WT littermates
maintained on a MacGreen background (Sasmono and Williams, 2012)
using a custom-built two-photon laser-scanning microscope (Till Pho-
tonics, Gräfelfing, Germany). EGFP was excited by a Chameleon Ultra II
laser (Coherent, Dieburg, Germany) at a wavelength of 940 nm. A 40×
water-immersion objective (NA 0.8, Olympus, Hamburg, Germany) was
used, with scanned 60 μm thick z-stacks and a step size of 3 μm cov-
ering a field of 384 × 384 μm2. Laser lesions were set to 40 μm under
the slice surface in the cortex by focusing the laser beam, set to a
wavelength of 810 nm and to maximum power in the selected imaging
volume, and scanned the tissue until autofluorescence of the injured
tissue was visible. This procedure resulted in lesions of ~ 20 μm in
diameter in the middle of the observed region. IGOR Pro 6.37 (Lake
Oswego, USA) was used for data analysis as in Davalos et al. (2005).
The sequences of 3D image stacks were converted into sequences of 2D
images by a maximum intensity projection algorithm. Grayscale images
were first converted into binary form using a threshold. For quantifi-
cation, microglial response to focal lesion was defined as EGFP+ pixel
count in a proximal circular region 45 μm around the lesion site over
time (Rx(t)). Distal fluorescence of the first time point was determined
within a diameter of 45 μm to 90 μm around the lesion site for nor-
malization (Ry(0)). Microglial responses are were represented as R
(t) = (Rx(t)-Rx(0))/Ry(0).
2.9. Microglia isolation by MACS
12–16 week male and female Nf1+/− and WT mice (n = 3 each)
were transcardially perfused with ice-cold Phosphate Buffered Saline
(PBS) to harvest the brain. Brains were subsequently homogenized at
0–4 °C in dissection buffer (HBSS, 45% glucose, 1 M HEPES) and cell
pellets were resuspended in 25 ml of 22% Percoll (GE Healthcare, Little
Chalfont, UK). The volume of 5 ml PBS was added as a layer on top.
Centrifugation was performed for 20 min at 950 g with medium ac-
celeration and no brakes to remove myelin and debris. Pellets were
resuspended in ice-cold MACS buffer and incubated with anti-mouse
CD11b antibodies coupled to magnetic beads (Miltenyi Biotech,
Bergisch Gladbach, Germany) for 15 min at 4 °C. Cells were re-
suspended in MACS buffer and passed through medium-sized MACS
columns (Miltenyi Biotech) attached to a magnet. The flow-through was
discarded and the cells were flushed out of the columns in MACS buffer,
collected by centrifugation, and stored at −80 °C for cAMP ELISA or
seeded in a 96 well plate for the cell viability assay.
2.10. RT-qPCR
Total RNA was extracted from acutely isolated microglia by MACS
using ReliaPrep RNA Miniprep System (Promega, Madison, Wisconsin,
USA). cDNA synthesis was performed using the PrimeScript™ RT re-
agent Kit (Takara, Kusatsu, Shiga, Japan). Quantitative real-time PCR
reactions to amplify 1 ng of total cDNA were performed in a 7500 Fast
Real-Time thermocycler (Applied Biosystems, Carlsbad, USA) using the
SYBR Select Master Mix (Applied Biosystems). CT values were nor-
malized using Hypoxanthin-Guanin-Phosphoribosyl-Transferase 1
(hprt1) as housekeeping gene. Primers were tested for their efficiency
beforehand, and the ΔΔCt-method was applied for analysis of relative
expression. To ensure the specificity of the PCR product, we analyzed
the melting curves of each product. Primer sequences were as follows
(gene: forward primer, reverse primer); Hprt1: GATTAGCGATGATGAA
CCAGGTT, CCTCCCATCTCCTTCATGACA; P2ry6: GCTGTGTCAGAGGG
AGTTTT, TGTCAGCCTTTCCTATGCTCG; P2ry12: GCACGGACACTTTC
CCGTAT, GCCTTGAGTGTTTCTGTAGGGTA; Tlr2: GACGACTGTACCCT
CAATGG, TTAAATGCTGGGAGAACGAG; Tlr4: AGACCTCAGCTTCAAT
GGTG, GAGACTGGTCAAGCCAAGAA; Tlr7: ATGTGGACACGGAAGAG
ACAA, GGTAAGGGTAAGATTGGTGGTG.
2.11. Multiplex immune assay
Cytokine detection was performed using the mouse High Sensitivity
5−plex Multiplex Immunoassay (Thermofisher Scientific, Waltham,
MA, USA) on microglial cell supernatants collected following stimula-
tion with LPS (100 ng/ml), Pam2CSK4 (100 ng/ml) or Loxoribine
(1 mM) for 24 h, according to the manufacturer's recommendations.
This magnetic bead-based assay enables the simultaneous detection and
quantification of multiple proteins in a single sample. Prior to incuba-
tion, samples were vortexed followed by centrifugation to remove
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particles. Protein detection was performed on a multiplexing plate
reader (Luminex 200, R&D Systems, Minneapolis, USA) and analyzed
using Bioplex System Software 4.0 (Bio-Rad, Hercules, CA, USA).
Cytokines analyzed included IL-6, TNF-α, IFN- γ, IL-2 and IL-4.
Expression levels are shown as Fluorescent Intensity (FI).
2.12. cAMP ELISA
cAMP levels were determined using the cyclic AMP ELISA Kit
(Biomol, Hamburg, Germany) according to the manufacturer's instruc-
tions. Briefly, MACS-isolated microglia were diluted in 50 μl HCl
(0.1 M) and centrifuged for 10 min at 1000 g. Supernatant was diluted
in 100 μl ELISA buffer to neutralize the acid. Sample acetylation was
performed by adding 30 μl KOH (4 M) and 7.5 μl acetic anhydride,
vortexing for 15 s and adding 7.5 μl KOH (4 M). Samples and standards
were pipetted into the ELISA plates and incubated for 18 h at 4 °C
before the plate was developed with Ellmann's reagent. Fluorescence
was measured at 420 nm using a plate reader (Luminex 200, R&D
Systems, Minneapolis, USA).
2.13. Cell viability assay
Cell viability was evaluated using the CellTiter-Glo® Luminescent
Cell Viability Assay Kit (Promega, Walldorf, Germany) according to the
manufacturer's instructions. Briefly, 2 × 104 MACS-isolated microglia
(in 100 μl PBS) were seeded into each well of a 96 well plate, followed
by the addition of 100 μl CellTiter Glo® reagent and vertical shaking for
10 min at 4 °C. Luminescence was determined using a luminescence
plate reader (Luminex 200, R&D Systems, Minneapolis, USA) after a
30 min incubation at room temperature. Three animals were used for
each condition (male and female WT and Nf1+/−), and three tech-
nical replicates were generated.
2.14. Statistics
All data are expressed as mean ± SEM. A combination of one-way
ANOVA tests with Tukey post hoc tests were employed to compare data
between the four experimental groups. Significance is always given as
*** p < .001, ** p < .01, * p < .05, n.s. p > .05.
3. Results
3.1. Microglia density and morphology are not altered by sex or Nf1
mutation
To determine whether Nf1 mutation or sex alters cellular and/or
microglia content in the brain, we first determined the density of mi-
croglia in cortex, hippocampus (CA2–3 region), subgranular zone (SGZ)
and amygdala from male and female Nf1+/− and WT mice. Using
DAPI to detect the total number of cells, we found no differences in
cellular densities with respect to sex or Nf1 mutation (Suppl. Fig. 1 and
Table 1). Similar results were obtained when the density of microglia
was quantified. In addition, microglial morphology (ramified versus
amoeboid appearance) was not different between groups.
3.2. Cytokine release following toll-like receptor stimulation is not different
between microglia from male and female WT and Nf1+/− mice
Toll-like receptors (TLRs) are expressed on microglia, where they
recognize pathogen-associated molecules, like bacterial and viral
components. Upon activation, TLR signaling culminates with the pro-
duction of inflammatory molecules. To characterize TLR responses, we
generated microglial cultures from adult (12–16 weeks) male and fe-
male WT and Nf1+/− mice, and stimulated them for 24 h with LPS,
LOX or Pam2CSK4 to activate TLR4-, TLR7- and TLR2-mediated path-
ways, respectively. The release of TNF-α, IL-6, IL-2, IL-4 and IFN-γ was
then measured from the culture supernatants using a multiplex ELISA
immunoassay. No differences between microglial cultures from male
and female WT and Nf1+/− mice were detected (Suppl. Fig. 2), in-
dicating that these inflammatory responses were not impacted by either
sex or Nf1 mutation. Consistent with these findings, no differences in
microglial Tlr2, Tlr4 and Tlr7 expression were observed between male
and female WT and Nf1+/− mice (Suppl. Fig. 4).
3.3. Phagocytic activity is reduced in Nf1+/− mice
Phagocytosis is an important function of microglia that enables
them to control synaptic density and plasticity, as well as to maintain
brain homeostasis under inflammatory conditions. To assay microglial
phagocytic activity, we employed cortical slices from male and female
Nf1+/− and WT mice between 14 and 16 weeks of age (Wendt et al.,
2017). Phagocytic activity was quantified by incubating the slices for
60 min with latex beads, and counting the number of beads in-
corporated into a 3D-rendered Iba1-labeled (microglia) volume using
confocal imaging and 3D reconstruction (Fig. 1 A). Per animal and
condition, we quantified microglial phagocytosis in 4–5 cortical brain
slices, analyzing 4–5 randomly chosen fields of view per slice by z-
stacks (cortex layers I–VI; 5–6 female and 5–6 male WT and Nf1+/−
mice each; 2–3 mice for AR-C66096 treatment, Fig. 1 A). As shown in
Fig. 1 B, baseline microglial phagocytosis was not significantly different
between female and male WT mice (male WT: 1.76 ± 0.12, n = 69
cells; female WT: 1.82 ± 0.13, n = 83 cells; p = .7220), consistent
with a previous study from our laboratory (Guneykaya et al., 2018). In
striking contrast, microglia from both male and female Nf1+/− mice
displayed reduced phagocytic activity relative to WT mice (male Nf1+/
−: 1.29 ± 0.09; n = 78 cells; p = .0026 vs male WT; female Nf1+/
−: 1.43 ± 0.11; n = 66 cells; p = .0209 vs female WT), indicating an
Nf1-dependent decrease in microglial phagocytosis.
Table 1
Cellular and microglial densities in different brain regions. (n = number of mice).
Brain region M WT M Nf1 F WT F Nf1 p value (ANOVA)
cells/mm2 n cells/mm2 n cells/mm2 n cells/mm2 n
Ctx 2773.2 ± 215.8 8 3207.8 ± 142.0 9 2913.4 ± 276.7 9 2895.0 ± 246.9 10 0.6005
HC 3075.9 ± 89.3 9 3129.5 ± 92.4 9 3063.9 ± 38.6 9 3178.0 ± 58.2 10 0.6574
SVZ 2917.1 ± 70.7 9 2973.9 ± 43.3 9 2754.3 ± 66.6 9 2855.4 ± 62.7 10 0.1007
Amy 3960.8 ± 182.4 8 3847.4 ± 110.1 8 3920.4 ± 86.3 8 4178.4 ± 108.5 8 0.4561
microglia/mm2 n microglia/mm2 n microglia/mm2 n microglia/mm2 n
Ctx 250.3 ± 31.6 7 267.5 ± 26.2 9 179.5 ± 16.9 9 225.4 ± 30.3 9 0.5034
HC 199.8 ± 22.7 9 212.9 ± 20.7 9 147.2 ± 17.9 9 174.5 ± 33.5 10 0.2867
SVZ 169.1 ± 35.6 9 116.0 ± 12.8 9 103.9 ± 23.2 9 103.7 ± 23 7 10 0.2279
Amy 321.7 ± 20.8 6 321.6 ± 32.9 8 261.2 ± 22.5 2 297.8 ± 26.6 8 0.3514
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3.4. Purinergic signaling alters microglial phagocytic activity in a sex- and
Nf1-dependent manner
It is well established that purinergic signaling controls microglial
phagocytosis, specifically through the purinergic receptors, P2RY6
(Koizumi et al., 2007; Xu et al., 2016; Wendt et al., 2017) and P2RY12
(Diaz-Aparicio et al., 2020). To examine the effect of purinergic sig-
naling on basal phagocytic activity in Nf1-mutant microglia, we eval-
uated P2RY6 and P2RY12 receptor signaling using receptor-specific
inhibitors (MRS2578, 5 μM and AR-C66096, 1 μM, respectively) (Fig. 1
C). MRS2578 reduced the phagocytic activity of microglia to a similar
level in all groups, male and female WT and Nf1+/−, suggesting that
Nf1-dependent reduction in basal phagocytosis of both sexes (Fig. 1 B)
is likely due to P2RY6-dependent mechanisms. However, treatment
with the P2RY6 ligand UDP (100 μM), enhanced phagocytosis in all of
the four groups (Fig. 1 D, Table 2) indicating that there was no general
failure in P2RY6 signaling in male and female Nf1+/− microglia. This
conclusion is also supported by our finding that there were no differ-
ences in P2ry6 mRNA levels between male and female WT and Nf1+/
− microglia (Suppl. Fig. 4).
P2RY12 inhibition reduced microglial phagocytosis similar to that
observed following P2RY6 blockade in male and female WT mice (Fig. 1
C, Table 2). Relative phagocytic activities in the presence of AR-C66096
were 0.80 ± 0.10 for male WT microglia (p < .001 vs. control and
p = .1676 vs. MRS2578) and 1.26 ± 0.16 for female WT microglia
(p < .001 vs. control and p = .1635 vs. MRS2578). Interestingly, AR-
C66096 did not decrease basal microglial phagocytosis in Nf1+/−
male mice (1.12 ± 0.11, n= 52; p= .2256 vs male Nf1+/− control),
indicating a reduced contribution of P2RY12 signaling to baseline
phagocytic activity. In female Nf1+/− mice, AR-C66096 reduced
microglial phagocytic activity similar to female WT mice (1.03 ± 0.14,
n = 27; p = .0291 vs female Nf1+/− control). Taken together, the
P2RY12-mediated microglia phagocytosis is altered in a sexually di-
morphic fashion in the setting of a heterozygous Nf1 mutation.
3.5. P2RY-dependent microglia membrane currents are impaired in male
Nf1+/− mice
Microglia express a variety of purinergic receptors, including
members of the metabotropic P2Y and ionotropic P2X receptor families.
We have previously shown that microglial membrane current responses
upon application of low (10 μM) ATP concentrations largely depend on
P2RY12 activation (Elmadany et al., 2020), which activates K+ cur-
rents through THIK-1 (Wendt et al., 2017; Boucsein et al., 2000;
Boucsein et al., 2003; Madry et al., 2018; Guneykaya et al., 2018). We
analyzed purinergic P2RY12 responses of microglia in acute cortical
slices from 14 to 16 week old male and female Nf1+/− mice using
standard whole-cell patch clamp techniques in the voltage-clamp con-
figuration. The microglial cells in each slice were identified by fluor-
escence labeling in WT and Nf1+/− mice intercrossed with MacGreen
(Csf1r-GFP) mice. Consistent with previous studies, WT microglia re-
sponded to 10 μM ATP with the induction of an outwardly rectifying
current that reversed close to the equilibrium potential for potassium.
We determined the specific conductance between +20 mV
and +60 mV to compare these currents in male and female microglia.
The conductance of microglial ATP-evoked potassium currents was
27.0 ± 4.6 pS/pF and 25.4 ± 5.2 pS/pF for male and female WT
microglia, respectively (n = 21 and n = 19 cells, respectively;
p = .8201, Fig. 2 A, B). Similar to the microglia phagocytosis results,
these microglial purinergic responses were reduced in male Nf1+/−
mice (15.7 ± 2.5 pS/pF; n = 36 cells; p = .0234 vs. male WT), in-
dicating an Nf1-dependent impairment. In contrast, 10 μM ATP re-
sponses of female Nf1+/− microglia (23.3 ± 5.9 pS/pF; n = 16 cells;
p = .9671) were not different from WT females, indicating a sexually
dimorphic impairment of P2RY12 signaling in the setting of an Nf1
mutation.
3.6. P2X-dependent purinergic membrane currents are not altered in
Nf1+/− mice
To analyze P2X receptor signaling, we measured microglial mem-
brane currents evoked by the application of 1 mM ATP (Fig. 2 C, D), a
concentration sufficient to activate P2RX7, the most common P2X re-
ceptor isoform in microglia (Butovsky et al., 2014; Ousingsawat et al.,
2015). 1 mM ATP application induced large membrane currents within
the application period (60 s), which were characterized by an inward
and outward component and a reversal potential close to 0 mV, con-
sistent with the characteristics of the non-selective cation channel
Fig. 1. Impaired phagocytic activity of microglia from Nf1+/− mice.
A: Representative confocal image (left) of Iba1-stained microglia (red) together with latex beads (blue) performed on brain slices from a representative 13-week-old
WT male mice. Right, 3D reconstructions of Iba1-positive microglia are shown with automatically counted phagocytosed beads (shown in black and indicated by
arrows). Scale bars, 50 μm.
B: Comparison of baseline phagocytic index of cortical microglia reveals lower levels in male and female Nf1+/− mice.
C: Control of microglial baseline phagocytosis by the P2ry6 and P2ry12 purinergic receptors. Blockade of P2ry6 by MRS2578 (5 μM) reduced baseline phagocytosis in
all four groups (male and female WT and Nf1+/− mice). Blockade of P2ry12 by AR-C66096 (1 μM) decreased microglial baseline phagocytosis only in male WT,
female WT, and female Nf1+/− mice, but not in male Nf1+/− mice.
D: P2ry6-mediated stimulation of microglial phagocytosis is dependent on sex or Nf1 mutation. Phagocytosis in the presence of the P2ry6 agonist UDP (100 μM), the
P2ry6 antagonist MRS2578 (5 μM), and UDP + MRS2578 are indicated. UDP-mediated stimulation of phagocytosis in all groups (male and female WT and Nf1+/−
mice) was blocked by MRS2578, indicating that P2ry6 signaling is unaffected by sex or Nf1 mutation.
The significance levels above the bars indicate the comparisons between WT and Nf1+/−mice; *** p < .001, ** p < .01, * p < .05, n.s. p > .05. Numbers in the
bars indicate the number of analyzed viewfields. Data were obtained from 3 to 9 mice and 12–36 slices per condition. (For interpretation of the references to colour in
this figure legend, the reader is referred to the web version of this article.)
Table 2
Purinergic receptors regulate microglia phagocytosis.
Condition ♂ WT ♂ Nf1 ♀ WT ♀ Nf1
engulfed beads*103/μm3 n engulfed beads*103/μm3 n engulfed beads*103/μm3 n engulfed beads*103/μm3 n
control 1,76 ± 0,12 69 1,29 ± 0,09 78 1,82 ± 1,13 83 1,43 ± 0,11 66
UDP 2,30 ± 0,14 81 1,74 ± 0,12 73 3,18 ± 0,22 84 2,17 ± 0,22 77
UDP &
MRS2578
1,68 ± 0,13 81 1,38 ± 0,09 60 1,69 ± 0,14 84 1,24 ± 0,08 73
MRS2578 0,99 ± 0,10 86 0,98 ± 0,08 75 1,00 ± 0,09 65 1,02 ± 0,08 64
AR-C66096 0,80 ± 0,10 51 1,12 ± 0,11 52 1,26 ± 0,16 43 1,03 ± 0,14 27
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(Fig. 2 C). The specific conductance between −100 mV and − 140 mV
was quantified to compare P2X-like currents in male and female WT
microglia. Conductances were 102.1 ± 18.2 pS/pF (n = 13 cells) and
122.8 ± 44.1 pS/pF (n = 7 cells) for male and female WT microglia,
respectively (p = .6150). P2X receptor-like currents in cortical micro-
glia from male and female Nf1+/− mice were similar to their WT
counterparts (89.9 ± 21.0 pS/pF; n= 14 cells; p= .6678 for male and
114.7 ± 36.4 pS/pF; n = 12 cells; p = .8920 for female), demon-
strating that the Nf1 mutational and sexually dimorphic differences in
microglia purinergic signaling were specific to metabotropic P2Y re-
ceptor signaling.
3.7. Basic membrane properties of microglia are not Nf1-dependent
Consistent with previous data from our laboratory and others (see
Kettenmann et al., 2011), microglia from 14 to 16 week old WT mice
display characteristic membrane currents when repetitively clamped at
potentials between −170 and +60 mV, starting from a holding po-
tential of −70 mV. Microglia are characterized by a high input re-
sistance and a small inwardly rectifying conductance between −40
and − 170 mV (Suppl. Fig. 3 A, B). The reversal potential, indicative of
the resting membrane potential, was −27.7 ± 1.2 mV (n = 27 cells)
and − 29.2 ± 2.2 mV (n = 23 cells) for male and female WT mi-
croglia, respectively (p = .5435), as previously described (Guneykaya
et al., 2018). The apparent membrane capacitance was not different
between the two sexes, with microglia from male WT mice having
21.0 ± 1.2 pF (n = 27 cells) and from female WT mice 23.2 ± 1.3 pF
(n = 11 cells; p = .2272; Suppl. Fig. 3 C, D). However, in contrast to
our previous study (Guneykaya et al., 2018), the amplitude of the in-
wardly rectifying currents were not significantly different between male
and female WT microglia (p = .2508). This could be potentially ex-
plained by differences in the mouse strains used in these two studies.
Additionally, cortical microglia from Nf1+/− mice did not differ from
their WT counterparts with respect to reversal potentials (male Nf1+/
−: n = 47 cells; p = .1589 vs WT; female Nf1+/−: n = 37 cells;
p = .3385 vs WT) and capacitance (male: p = .9342; female:
p = .3553). Inwardly rectifying currents were also not different be-
tween male (p = .0681) or female (p = .0754). WT and Nf1+/−
microglia. Taken together, there are no sex-dependent differences in the
electrophysiological profiles of cortical microglia in normal mice or in
the setting of an Nf1 mutation.
3.8. Microglial process extension is impaired in male Nf1+/− mice
Another P2RY12-mediated function in microglia is process exten-
sion in response to injury (Haynes et al., 2006; Madry et al., 2018;
Guneykaya et al., 2018), where microglia respond with targeted
movement of their processes towards the lesion site (Nimmerjahn et al.,
2005; Davalos et al., 2005). Microglial responses in acute brain slices of
adult (13–15 weeks) male and female WT and Nf1+/− mice on a
MacGreen background were analyzed following a laser lesion by two-
photon imaging. The movement of microglial processes was quantified
by determining the fluorescence distribution within the area of con-
centric circles (45 μm and 90 μm) around the lesion site (for details, see
Materials and Methods; Fig. 3 A). The response of male WT microglia
30 min after the laser lesion was 0.043 ± 0.004 (n = 21 cells), which
was greater than observed in female WT microglia (0.027 ± 0.002;
n = 26 cells; p = .0014). No translocation of microglial cell bodies was
seen during the observation period. In contrast, whereas female Nf1+/
− microglia exhibited no differences (0.021 ± 0.003; n = 20 cells;
p = .4798) relative to their WT counterparts, process extension in male
Nf1+/− microglia was decreased to 0.015 ± 0.002 (n = 20 cells;
p < .0001) relative to male WT controls.
3.9. Microglial cAMP levels are reduced in male Nf1+/− mice
To determine the basis for the sexual dimorphism in microglia
purinergic signaling observed in male Nf1+/−mice, we first examined
P2RY6 and P2RY12 mRNA expression in acutely isolated microglia
from adult mouse brains (14–16 weeks). Following MACS (CD11b)
isolation, qPCR using P2RY6- and P2RY12-specific primers (Suppl.
Fig. 4) revealed no differences in mRNA expression between male and
female WT and Nf1+/− microglia, excluding receptor expression le-
vels as the causative etiology for the differences in purinergic signaling.
Next, we examined intracellular cAMP levels, based on prior studies
in astrocytes (Dasgupta et al., 2003; Anastasaki and Gutmann, 2014)
and the fact that purinergic signaling results in increased cAMP gen-
eration (Post et al., 1996; Post et al., 1998). Microglia were isolated
from whole brains of male and female WT and Nf1+/− mice
(12–16 weeks) by MACS using CD11b antibodies, and subjected to
ELISA to measure intracellular cAMP levels (Fig. 4 A). We first per-
formed a cell viability assay on MACS-isolated microglia from the four
groups and excluded potential sex- or genotype-dependent differences
in microglial persistence to the MACS isolation procedure (Suppl.
Fig. 5). cAMP levels were similar in female (1.8 ± 0.3 pg/ml, n = 3
mice) and male (2.5 ± 0.1 pg/ml; n = 3 mice; p = .1772) WT mi-
croglia, however, reduced microglial cAMP levels were observed in
male Nf1+/− (1.4 ± 0.3 pg/ml, n = 3 mice) relative to WT
(p= .0301) microglia (Fig. 4 B). In contrast, female Nf1+/− microglia
(1.7 ± 0.1 pg/ml, n = 3 mice) did not differ from WT controls
(p = .9950), indicating that microglial cAMP levels are affected by Nf1
mutation in a sexually-dimorphic manner.
3.10. Increasing intracellular cAMP levels rescues male Nf1+/− microglia
phenotypes
To restore intracellular cAMP levels in microglia, we took advantage
of the preferential expression of the phosphodiesterase (PDE) 3B sub-
type in microglia, and used cilostamide, a selective PDE3 inhibitor, to
increase cAMP levels in microglia in situ (Bernier et al., 2019). Treat-
ment with 10 μM cilostamide for 10 min resulted in a normalization of
ATP-(10 μM) induced outward currents in microglia from male Nf1+/
− mice similar to levels observed in WT male microglia (Fig. 4 C, D). In
addition, cilostamide treatment also ameliorated the male Nf1+/−
microglia defect in directed process movement towards a laser lesion.
Pretreatment of slices with 10 μM cilostamide for 10 min partly cor-
rected the movement defect in male Nf1+/− microglia (Fig. 4 E, F).
Taken together, these data establish that the sexually dimorphic Nf1+/
Fig. 2. Nf1-dependent alterations in microglial purinergic membrane current responses.
A and C: Representative patch-clamp recordings from male and female WT and Nf1+/− microglia. From a holding potential of −20 mV, cells were repetitively
clamped at a series of potentials between −140 and +60 mV every 5 s. Application of 10 μM ATP (A) or 1000 μM ATP (C) is indicated by the bars. Note the typical
metabotropic purinergic response to 10 μM ATP with activation of outwardly rectifying currents (A) and the typical P2X-like induction of a cationic conductance
upon 1000 μM ATP (C) exposure.
B and D: Averaged current density-voltage relationships of currents evoked by 10 μM ATP (B) or 1000 μM ATP (D). Current responses were obtained by subtraction of
microglial membrane currents prior to and in the presence of 10 μM (B) or 1000 μM (D) ATP, followed by normalization to the capacitance.
Male Nf1+/− mice displayed significantly smaller metabotropic purinergic responses (ANOVA/Tukey). Number of recorded cells (mice): male WT, 26 (12); male
Nf1+/−, 29 (14); female WT, 19 (11); female Nf1+/−, 16 (10).
There were no significant sex- or Nf1-dependent differences in P2X-like currents (ANOVA/Tukey).
Number of recorded cells (mice): male WT, 13 (9); male Nf1+/−, 14 (11); female WT, 7 (6); female Nf1+/−, 12 (9).
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− microglia purinergic signaling defects result from alterations in in-
tracellular cAMP levels.
4. Discussion
In this report, we demonstrate that sex and genotype interact to
result in male-specific defects in microglial purinergic signaling,
leading to impaired phagocytosis, process movement, and membrane
currents. These observations fortify prior observations that male mi-
croglia contribute differentially to brain pathology. For example,
P2RX4 is uniquely induced in male microglia after injury (Sorge et al.,
2015), resulting in male pain hypersensitivity. Similarly, male, but not
female, microglia exhibit ATP-dependent p38-MAPK phosphorylation
and brain-derived neurotrophic factor (BDNF) release (Mapplebeck
Fig. 3. Injury-directed process movement activity is decreased in male Nf1+/− microglia.
A: Representative pictures of injury-induced process movement of EGFP-positive microglia in the cortex of acute brain slices from male and female WT and Nf1+/−
mice. Acute injury was induced by a focal laser lesion (left images) and microglial movement activity was recorded for 30 min (right images). Yellow lines indicate
the concentric circles (solid: 45 μm; dotted: 90 μm) around the lesion site used for offline quantification of microglial process movements.
B: Quantitative analysis of lesion-induced, microglial process movement expressed in arbitrary units (AU) in male and female WT and Nf1+/− mice. (For inter-
pretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Male Nf1+/− microglia displayed significantly weaker process responses than male WT microglia. Number of experiments (and mice): male WT, 21 (9); male
Nf1+/−, 20 (6); female WT, 26 (9); female Nf1+/−, 20 (6).
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et al., 2018). While these sex differences could reflect the differential
expression of purinergic receptors (e.g., P2RX4, P2RX7, P2RY12) in
male microglia (Guneykaya et al., 2018), this was not the etiology for
the sex-by-genotype effects observed in male Nf1-mutant microglia.
Instead, we discovered that cAMP differences in male Nf1+/− mi-
croglia underlie these sexually dimorphic phenotypes in young adult
mice (12–16 weeks of age). As age affects microglial function and sex
differences throughout lifespan, these sex by genotype effects might be
different in older or younger mice.
The role of cAMP in microglia ramification and process movement
has previously been shown using PDE inhibitors and G protein-coupled
receptor activation (Bernier et al., 2019). In addition, norepinephrine-
dependent changes in microglial morphology and function in awake
and anesthetized mice are cAMP dependent (Stowell et al., 2019; Liu
et al., 2019). In the setting of Nf1 mutation, the Nf1 protein (neurofi-
bromin) controls cAMP homeostasis in human and mouse neurons
through RAS-mediated activation of an atypical Protein Kinase-C
(PKCζ), resulting in reduced G protein-coupled receptor stimulation of
(caption on next page)
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adenylyl cyclase (Anastasaki and Gutmann, 2014). However, it is not
known how neurofibromin regulates cAMP homeostasis in microglia or
whether the observed sexual dimorphic effects involve gonadal sex
hormone or sex chromosome differences (Arnold, 2009), microbiome
influences (Thion et al., 2018) or the differential expression of reg-
ulatory microRNAs (Kodama et al., 2020).
In patients with NF1, impulsivity and hyperactivity is more common
in boys than girls (Cohen et al., 2018), and, as seen in the general po-
pulation, there is a male bias in the prevalence of autism spectrum
disorders (ASD) in children with NF1 (Garg et al., 2016). In this regard,
previous studies from our laboratory demonstrated that male, but not in
female, Nf1+/− mice exhibit reduced hippocampal dopamine levels,
increased RAS/ERK activity, and impaired spatial learning (Diggs-
Andrews et al., 2014b). In the current study, we investigated microglial
cells, which are, particularly during early postnatal stages, critical for
the development and homeostasis of neuronal networks, mainly due to
their ability to prune synapses (Tremblay et al., 2011; Kettenmann
et al., 2013; Bilimoria and Stevens, 2015; Michell-Robinson et al.,
2015). As such, there is growing evidence for a crucial role of microglia
in the development psychiatric disorders including schizophrenia
(Mattei et al., 2014) and ASD (Petrelli et al., 2016). Since no direct
evidence exists for such a causal link in the setting of NF1, future stu-
dies will be required to elucidate the impact of reduced microglial
P2RY12 activity on social interaction phenotypes in male and female
Nf1-mutant mice.
Taken together, the finding of sexually dimorphic differences in
microglia harboring a germline Nf1 mutation adds to the growing
number of sex-specific abnormalities described in microglia, including
differences in morphology (Lenz et al., 2013), function (Nelson et al.,
2017), and density (Schwarz et al., 2012; Vanryzin et al., 2019). In
addition, male and female microglia also have different rates of tran-
scriptional maturation and immune reactivity (Hanamsagar et al.,
2017; Guneykaya et al., 2018). Some of these differences may be “hard
wired” by sex, given that female microglia offer protection in the face of
ischemic injury when transplanted into male brains (Villa et al., 2018).
Understanding how these sex differences are established and main-
tained will provide new insights into our understanding of the interplay
between risk factors and cellular function in the brain.
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